AN
₹854.45
+24.45(+2.95%)
ANTHEM₹854.45+2.95%
Group Companies
Foreign Flows
sector level — not this stockHealthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-endThis is the flow into the whole Healthcare sector, not into ANTHEM. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.
Supply Chain
suppliers and customers in the graphMacro Sensitivity
rates, currency, commoditiesRevenue by Segment
Business Group
Geographic Exposure
revenue, imports, currencyScenario analysis
stated assumptions, shown workingsANTHEM exposure summary
In its latest segment disclosure (Jun 2026), CRDMO was the largest segment at 81.5% of segment revenue, followed by Speciality Ingredients at 18.5%. Anthem Biosciences Limited is a constituent of 5 indices, with its largest weights in NIFTY India Manufacturing (0.19%), S&P BSE 500 (0.05%), NIFTY 500 (0.05%). 12 exchange-traded funds hold the stock.
| Index memberships | 5 |
|---|---|
| ETFs holding | 12 |
| Largest segment | CRDMO · 81.5% |